Correlation Between Enlivex Therapeutics and Vacasa
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Vacasa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Vacasa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Vacasa Inc, you can compare the effects of market volatilities on Enlivex Therapeutics and Vacasa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Vacasa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Vacasa.
Diversification Opportunities for Enlivex Therapeutics and Vacasa
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enlivex and Vacasa is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Vacasa Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vacasa Inc and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Vacasa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vacasa Inc has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Vacasa go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Vacasa
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Vacasa. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 1.2 times less risky than Vacasa. The stock trades about 0.0 of its potential returns per unit of risk. The Vacasa Inc is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 325.00 in Vacasa Inc on November 2, 2024 and sell it today you would earn a total of 180.00 from holding Vacasa Inc or generate 55.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Vacasa Inc
Performance |
| Timeline |
| Enlivex Therapeutics |
| Vacasa Inc |
Enlivex Therapeutics and Vacasa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Vacasa
The main advantage of trading using opposite Enlivex Therapeutics and Vacasa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Vacasa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vacasa will offset losses from the drop in Vacasa's long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |